Oppenheimer Starts Demandware (DWRE) at Outperform
Get Alerts DWRE Hot Sheet
Price: $74.97 --0%
Rating Summary:
10 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Oppenheimer initiates coverage on Demandware (NYSE: DWRE) with a Outperform. PT $35.00.
The firm comments, "Led by an experienced management team, DWRE is targeting a large and rapidly growing market via multiple growth avenues. The company provides differentiated software-as-a-service (SaaS) technology that enables customers to easily design, implement and manage their own customized e-commerce sites, including websites, mobile applications and digital storefronts. DWRE's SaaS financial model provides meaningful top-line visibility, and proprietary technology creates a formidable barrier to entry."
For an analyst ratings summary and ratings history on Demandware click here. For more ratings news on Demandware click here.
Shares of Demandware closed at $28.28 yesterday.
The firm comments, "Led by an experienced management team, DWRE is targeting a large and rapidly growing market via multiple growth avenues. The company provides differentiated software-as-a-service (SaaS) technology that enables customers to easily design, implement and manage their own customized e-commerce sites, including websites, mobile applications and digital storefronts. DWRE's SaaS financial model provides meaningful top-line visibility, and proprietary technology creates a formidable barrier to entry."
For an analyst ratings summary and ratings history on Demandware click here. For more ratings news on Demandware click here.
Shares of Demandware closed at $28.28 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- BMO Capital Resumes Snowline Gold Corp (SGD:CN) (SNWGF) at Outperform
- Leerink Starts Ligand Pharma (LGND) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share